Jordi Codony-Servat

1PUBLICATIONS
0CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Sep 07, 2022
Anti-EGF nanobodies enhance the antitumoral effect of osimertinib and overcome resistance in non-small cell lung cancer (NSCLC) cellular models.

Salvador Guardiola, Macarena Sánchez-Navarro, Rafael Rosell

Pageof 1

Frequent Collaborators